Industry Experts

Yalda Sedaghat is a strategic leader in RNA therapeutics with over 17 years of experience in drug discovery. She currently serves as Scientific Deputy Modality Lead and Senior Project Leader at Evotec, driving innovation in oligonucleotide therapeutics for neurodegenerative and metabolic disorders. Previously, at Ionis Pharmaceuticals, she advanced antisense oligonucleotide programs for ALS and Huntington’s disease, validating potent ASOs for preclinical studies. Her expertise spans ASOs, siRNA, and AAV gene editing, with a proven track record from target validation to IND‑enabling studies. A recognized collaborator and communicator, she is passionate about advancing RNA‑based medicines to transform patient outcomes.